Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
Sang‐Mo Hong; Cheol‐Young Park; Dong‐Min Hwang; Kyung Ah Han; Chang Beom Lee; Choon Hee Chung; Kun‐Ho Yoon; Ji‐Oh Mok; Kyong Soo Park; Sung‐Woo Park
Author Information: Department of Internal Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.